SAFETY AND EFFICACY OF INSULIN GLARGINE/LIXISENATIDE AND INSULIN DEGLUDEC/INSULIN ASPART IN TYPE 2 DIABETES PATIENTS NOT CONTROLLED ON BASAL INSULIN: A NETWORK META-ANALYSIS

被引：0

作者：

Jammah, A. ^{[1
]}

机构：

[1] King Saud Univ, Dept Endocrinol, Riyadh, Saudi Arabia

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

394

引用

页码：A185 / A186

页数：2

共 50 条

[41] Efficacy of Insulin Glargine Plus 1 Injection of Insulin Glulisine in Patients with Type 2 Diabetes Inadequately Controlled by Insulin Glargine
Charpentier, Guillaume
DIABETES, 2014, 63 : A237 - A237
[42] Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes
Dardano, Angela
Bianchi, Cristina
Del Prato, Stefano
Miccoli, Roberto
VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 465 - 475
[43] Low Fasting Glucose and Insulin Deficiency Were Related with Superiority of Insulin Degludec/Aspart Compared with Basal Insulin in Patients with Type 2 Diabetes
Jang, Han Na
Yang, Ye Seul
Oh, Tae Jung
Koo, Bo Kyung
Lee, Seongok
Jung, Hye Seung
DIABETES, 2021, 70
[44] Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta-analysis and cost-effectiveness analysis
Men, Peng
Qu, Shuli
Luo, Wenting
Li, Chaoyun
Zhai, Suodi
DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 107 - 115
[45] Insulin Glargine/Lixisenatide: A Review in Type 2 Diabetes
Scott, Lesley J.
DRUGS, 2017, 77 (12) : 1353 - 1362
[46] Type 2 Diabetes: Direct Comparison between Insulin Glargine and Insulin Degludec
Lichert, Frank
DIABETOLOGIE UND STOFFWECHSEL, 2018, 13 (06) : 546 - 546
[47] Type 1 diabetes patients can temporarily switch from continuous subcutaneous insulin infusion with insulin aspart to basal bolus therapy with insulin aspart and insulin glargine
Bode, B
Hirsch, I
Hu, P
Santiago, O
DIABETES, 2003, 52 : A102 - A102
[48] Efficacy and safety of switching to insulin icodec, a once-weekly basal insulin, vs insulin glargine U100 in patients with type 2 diabetes inadequately controlled on OADs and basal insulin
Bajaj, H.
Isendahl, J.
Gowda, A.
Stachlewska, K.
Rosenstock, J.
DIABETOLOGIA, 2020, 63 (SUPPL 1) : S317 - S317
[49] Insulin Glargine/Lixisenatide: A Review in Type 2 Diabetes
Lesley J. Scott
Drugs, 2017, 77 : 1353 - 1362
[50] Diabetes in Pregnancy: A Meta-Analysis of the Safety of Insulin Glargine Compared with NPH Insulin
Lepercq, Jacques
Lin, Jay
Hall, Gillian
Dain, Marie-Paule
Riddle, Matthew
Home, Philip
DIABETES, 2011, 60 : A259 - A260

← 1 2 3 4 5 →